CCND1 and prostate carcinoma: To functionally assess the role of eRNA in tumor cells, we employed CRISPRi to suppress the enhancer activity of CCND1e in PC3 prostate cancer cells, which resulted in a marked decrease in the expression of both CCND1e and its target gene, CCND1 (Figure 5H,I).